Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Xueshi Ye"'
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Disseminated candidiasis is a severe complication in patients with hematological malignancies who have undergone chemotherapy or hematopoietic stem cell transplantation. It has a high mortality rate. When disseminated candidiasis caused by Candida tr
Externí odkaz:
https://doaj.org/article/97b17748b8ac4bf59123f210c607434d
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract With the exception of high-dose methotrexate (HD-MTX), there is currently no defined standard treatment for newly diagnosed primary central nervous system lymphoma (PCNSL). This review focused on first-line induction and consolidation treatm
Externí odkaz:
https://doaj.org/article/3170ff54733d4395aa0b2557dcab7c0b
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Circulating cell-free DNA (cfDNA) detection, a non-invasive method, appears promising for genetic analyses as well as quantitative assessment of tumor burden in patients with cancer. Although the analysis of cfDNA for clinical prognosis and monitorin
Externí odkaz:
https://doaj.org/article/6395e659287646d081ffe480e4ba0fae
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
To date, multiple myeloma remains an incurable disease. Immunotherapy is an encouraging option in the development of multiple myeloma (MM) therapy. CS1 is a specific myeloma antigen, which is highly expressed in myeloma cells. Calreticulin (CRT) is a
Externí odkaz:
https://doaj.org/article/3296779fca11459696b38882c9e9e24c
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e72635 (2013)
BACKGROUND: Although high-dose therapy (HDT) with autologous stem cell transplantation (ASCT) has been confirmed to result in longer remission time than conventional chemotherapy, multiple myeloma (MM) remains incurable. Post-ASCT maintenance is cons
Externí odkaz:
https://doaj.org/article/c8c5cac0f1c44b1b88f6fb0ff8e4576d
Autor:
Ping Huang, Jianwen Chen, Yaoqiang Lao, Gongyun He, Xueshi Ye, Wang Yang, Ruiqi Su, Xiangjun He, Jinguo Shi, Caibao Jiang, Jingxia Zhang
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12ae1d23d717863a0f1cbecbe57cb008
https://doi.org/10.2139/ssrn.4040876
https://doi.org/10.2139/ssrn.4040876
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
With the exception of high-dose methotrexate (HD-MTX), there is currently no defined standard treatment for newly diagnosed primary central nervous system lymphoma (PCNSL). This review focused on first-line induction and consolidation treatment of PC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e26a648f5cd5bd2feee8ef78a09552dd
https://doi.org/10.1038/s41598-020-80724-0
https://doi.org/10.1038/s41598-020-80724-0
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
To date, multiple myeloma remains an incurable disease. Immunotherapy is an encouraging option in the development of multiple myeloma (MM) therapy. CS1 is a specific myeloma antigen, which is highly expressed in myeloma cells. Calreticulin (CRT) is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42f4b0c8a3bddf001b59c43570357842
https://pubmed.ncbi.nlm.nih.gov/33330069
https://pubmed.ncbi.nlm.nih.gov/33330069
Publikováno v:
Leukemia Research. 33:1114-1119
Multidrug-resistance (MDR) is a major hindrance to successful chemotherapy. The emergence of MDR is multi-factorial. Among them, the MDR1 gene/P-glycoprotein (P-gp) is a popular and important reason. In our study, an MDR1 single-factorial drug-resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdf98eaf681042c2b04b30162e2acbf3
https://doi.org/10.1016/j.leukres.2008.10.011
https://doi.org/10.1016/j.leukres.2008.10.011
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 8, p e72635 (2013)
PLoS ONE, Vol 8, Iss 8, p e72635 (2013)
BACKGROUND: Although high-dose therapy (HDT) with autologous stem cell transplantation (ASCT) has been confirmed to result in longer remission time than conventional chemotherapy, multiple myeloma (MM) remains incurable. Post-ASCT maintenance is cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::644d2751e71dc0e0db69d4fc65e27009
https://pubmed.ncbi.nlm.nih.gov/23977334
https://pubmed.ncbi.nlm.nih.gov/23977334